ALT-B5

N/A

Report date: 2025/01/23 11:41:25

Base Information

Drug NameALT-B5
Drug Alias Namelong-acting GH receptor antagonist fusion proteinALT-B5
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGrowth hormone receptor antagonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlteogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlteogen Inc
Inactive CompaniesN/A
Active IndicationsAcromegaly
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A